InMed Pharmaceuticals Inc.
INM · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$8,162 | -$7,676 | -$7,948 | -$18,600 |
| Dep. & Amort. | $535 | $605 | $596 | $512 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $119 | $138 | $278 | $698 |
| Change in WC | -$337 | -$369 | -$566 | -$3,073 |
| Other Non-Cash | $78 | $317 | $356 | $4,880 |
| Operating Cash Flow | -$7,767 | -$6,986 | -$7,283 | -$15,584 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$9 | -$162 | -$39 |
| Net Acquisitions | $0 | $0 | -$500 | -$209 |
| Inv. Purchases | -$42 | -$42 | -$42 | $0 |
| Inv. Sales/Matur. | $42 | $42 | $42 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$425 |
| Investing Cash Flow | $0 | -$9 | -$662 | -$673 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | -$291 |
| Stock Issued | $8,130 | $5,216 | $10,680 | $17,146 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,141 | -$562 | $1 | -$1,785 |
| Financing Cash Flow | $12,271 | $4,654 | $10,681 | $15,070 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $4,504 | -$2,341 | $2,736 | -$1,186 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6,572 | $8,913 | $6,177 | $7,363 |
| End Cash | $11,076 | $6,572 | $8,913 | $6,177 |
| Free Cash Flow | -$7,767 | -$6,995 | -$7,445 | -$15,623 |